×

Heterocyclic ITK inhibitors for treating inflammation and cancer

  • US 9,695,200 B2
  • Filed: 01/25/2016
  • Issued: 07/04/2017
  • Est. Priority Date: 01/23/2015
  • Status: Active Grant
First Claim
Patent Images

1. A compound, or a pharmaceutically acceptable salt, hydrate or solvate thereof, of Formula (I):

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×